Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2017

Market: Pharmaceuticals and Healthcare

Global, 1430 pages report, published by Global Markets Direct

Report ThumbnailJune-2017
Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2017, provides an overview of the Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape.

Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor. GBMs arise from glial cells, which are cells that form the tissue that surrounds and protects other nerve cells found wit

Read More
  • List of Figures
  • Number of Products under Development for Glioblastoma Multiforme (GBM), H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Universities/Institutes, H1 2017
  • Number of Products by Top 10 Targets, H1 2017
  • Number of Products by Stage and Top 10 Targets, H1 2017
  • Number of Products by Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Top 10 Routes of Adm
Read More
  • List of Tables
  • Number of Products under Development for Glioblastoma Multiforme (GBM), H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..4), H1 2017
  • Number of Products under Devel
Read More
  • Table of Contents
  • Table of Contents 2
  • Introduction 10
  • Glioblastoma Multiforme (GBM) - Overview 11
  • Glioblastoma Multiforme (GBM) - Therapeutics Development 12
  • Glioblastoma Multiforme (GBM) - Therapeutics Assessment 57
  • Glioblastoma Multiforme (GBM) - Companies Involved in Therapeutics Development 83
  • Glioblastoma Multiforme (GBM) - Drug Profiles 181
  • Glioblastoma Multiforme (GBM) - Dormant Projects 1365
  • Glioblastoma Multiforme (GBM) - Discontinued Products 1375
  • Glioblastoma Multiforme (GBM) - Produc
Read More

Please select a license type

Share

Related Products

Global Markets DirectGlioblastoma Multiforme (GBM) - Pipeline Review, H1 2017Product ThumbnailGlioblastoma Multiforme (GBM) - Pipeline Review, H1 2017, Industry ReportProduct #: 829033
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2018 Global Market Analyst. All Rights Reserved